SOURCES:

Philip Robinson, MBChB, PhD, associate professor, The University of Queensland, Australia.

Eric M. Ruderman, MD, professor of medicine (rheumatology), associate chief, clinical affairs for the division of rheumatology, Northwestern University Feinberg School of Medicine.

Ali Ajam, MBBS, The Ohio State University Wexner Medical Center.

Rheumatology and Therapy: “Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy.

Expert Review of Clinical Immunology: “Radiographic progression in non-radiographic axial spondyloarthritis.”

American College of Rheumatology: “Predicting Progression of Non-Radiographic Axial Spondyloarthritis.”

PLOS One: “Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.”

RMD Open: “Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?”

Annals of the Rheumatic Diseases: “Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis.”

UpToDate: “Patient education: Axial spondyloarthritis, including ankylosing spondylitis (Beyond the Basics)”

Spondylitis Association of America: “How Disease Severity, Ethnicity, and HLA-B27 Prevalence Intersect,” “Overview of Ankylosing Spondylitis.”

Lab Tests Online: “Ankylosing Spondylitis.”

Source link

You May Also Like

Common Medications You Shouldn’t Be on for Long

Analysis by Dr. Joseph Mercola Fact Checked October…

There’s a New Covid-19 Variant and Cases Are Ticking Up. What Do You Need to Know? – KFF Health News

It’s winter, that cozy season that brings crackling fireplaces, indoor gatherings —…

Psychosis: Will catching early warning signs help? – Harvard Health

Programs aim to support those at risk for psychosis or experiencing a…

Blockbuster drug Humira finally faces lower-cost rivals

AbbVie’s Humira was the world’s best-selling drug for many years. Now it…